CDK13-related disorder

Autosomal dominant - en

CDK13-related disorder Hamilton

CDK13-related disorder is a rare genetic condition characterized by a range of developmental and physical anomalies. This disorder is caused by mutations in the CDK13 gene, which plays a crucial role in the regulation of cell cycle progression and transcription. The CDK13 gene encodes a member of the cyclin-dependent kinase family, which are serine/threonine kinases involved in controlling the cell cycle and gene expression.

Symptoms and Clinical Features

Patients with CDK13-related disorder present a spectrum of clinical manifestations, which can vary significantly among affected individuals. Common features include developmental delay, intellectual disability, and distinctive facial features. These facial features may include a high forehead, hypertelorism (widely spaced eyes), epicanthal folds, and a thin upper lip. Congenital heart defects, such as septal defects, and other anomalies like skeletal malformations, may also be present. Additionally, some individuals may exhibit autistic behaviors or have difficulties with speech and language development.

Genetics

CDK13-related disorder is inherited in an autosomal dominant manner, meaning a mutation in just one of the two copies of the CDK13 gene is sufficient to cause the disorder. The mutations are often de novo, meaning they occur spontaneously in the affected individual and are not inherited from the parents. The CDK13 gene is located on chromosome 7q21 and encodes a protein that is involved in the regulation of transcription and cell cycle progression.

Diagnosis

The diagnosis of CDK13-related disorder is primarily based on clinical evaluation and the identification of a pathogenic mutation in the CDK13 gene through genetic testing. Molecular genetic testing, such as whole exome sequencing or targeted gene panels, is used to detect mutations in the CDK13 gene. Prenatal diagnosis is possible if a pathogenic mutation has been identified in a family.

Management and Treatment

There is no cure for CDK13-related disorder, and management is focused on the symptomatic treatment and supportive care. Early intervention programs that include physical, occupational, and speech therapy can help improve developmental outcomes. Regular follow-up with a multidisciplinary team is important to monitor and manage the various aspects of the disorder, including developmental progress, cardiac anomalies, and other potential complications.

Prognosis

The prognosis for individuals with CDK13-related disorder varies depending on the severity of the symptoms and the presence of congenital anomalies. With appropriate management and supportive care, many individuals can achieve a good quality of life. However, the developmental delays and intellectual disability associated with the disorder are typically lifelong.

Research

Research on CDK13-related disorder is ongoing, with studies aimed at understanding the molecular mechanisms underlying the disorder and developing targeted therapies. As a rare condition, patients and families may also benefit from participation in research studies and patient registries, which can help advance knowledge and improve care for individuals with this disorder.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian